Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Middle Meningeal Artery Embolization versus Surgery in Patients with Chronic Subdural Hematoma-No More Fence Sitting

D. Sila, FL. Casnati, M. Vojtková, P. Kirsch, S. Rath, F. Charvát

. 2023 ; 15 (4) : 1480-1488. [pub] 20231206

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23022365

BACKGROUND: Endovascular treatment of patients with chronic subdural hematoma using middle meningeal artery (MMA) embolization could become an alternative to surgical hematoma evacuation. The aim of the study was to compare methods and identify parameters to help determine the correct treatment modality. METHODS: We retrospectively reviewed 142 cases conducted internally; 78 were treated surgically and 64 were treated using MMA embolization. We analyzed the treatment failure rate and complications, and using a binary logistic regression model, we identified treatment failure risk factors. RESULTS: We found a comparable treatment failure rate of 23.1% for the surgery group and 21.9% for the MMA embolization group. However, in the MMA embolization group, 11 cases showed treatment failure due to early neurological worsening with a need for concomitant surgery. We also found a recurrence of hematoma in 15.4% of cases in the surgery group and 6.3% of cases in the MMA embolization group. CONCLUSION: Both modalities have their advantages; however, correct identification is crucial for treatment success. According to our findings, hematomas with a maximal width of <18 mm, a midline shift of <5 mm, and no acute or subacute (hyperdense) hematoma could be treated with MMA embolization. Hematomas with a maximal width of >18 mm, a midline shift of >5 mm, and no membranous segmentation could have better outcomes after surgical treatment.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23022365
003      
CZ-PrNML
005      
20240116163022.0
007      
ta
008      
240105s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/neurolint15040096 $2 doi
035    __
$a (PubMed)38132975
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Sila, Dalibor $u Department of Neurosurgery and Interventional Neuroradiology, Donau Isar Klinikum Deggendorf, Perlasberger Str. 41, 94469 Deggendorf, Germany $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague, Military University Hospital, U Vojenské Nemocnice 1200, 16902 Praha, Czech Republic
245    10
$a Middle Meningeal Artery Embolization versus Surgery in Patients with Chronic Subdural Hematoma-No More Fence Sitting / $c D. Sila, FL. Casnati, M. Vojtková, P. Kirsch, S. Rath, F. Charvát
520    9_
$a BACKGROUND: Endovascular treatment of patients with chronic subdural hematoma using middle meningeal artery (MMA) embolization could become an alternative to surgical hematoma evacuation. The aim of the study was to compare methods and identify parameters to help determine the correct treatment modality. METHODS: We retrospectively reviewed 142 cases conducted internally; 78 were treated surgically and 64 were treated using MMA embolization. We analyzed the treatment failure rate and complications, and using a binary logistic regression model, we identified treatment failure risk factors. RESULTS: We found a comparable treatment failure rate of 23.1% for the surgery group and 21.9% for the MMA embolization group. However, in the MMA embolization group, 11 cases showed treatment failure due to early neurological worsening with a need for concomitant surgery. We also found a recurrence of hematoma in 15.4% of cases in the surgery group and 6.3% of cases in the MMA embolization group. CONCLUSION: Both modalities have their advantages; however, correct identification is crucial for treatment success. According to our findings, hematomas with a maximal width of <18 mm, a midline shift of <5 mm, and no acute or subacute (hyperdense) hematoma could be treated with MMA embolization. Hematomas with a maximal width of >18 mm, a midline shift of >5 mm, and no membranous segmentation could have better outcomes after surgical treatment.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Casnati, Francisco Luis $u Department of Neurosurgery and Interventional Neuroradiology, Donau Isar Klinikum Deggendorf, Perlasberger Str. 41, 94469 Deggendorf, Germany
700    1_
$a Vojtková, Mária $u Department of Statistics, Faculty of Economic Informatics, University of Economics in Bratislava, Dolnozemská Cesta 1/b, Bratislava 85235, Slovakia $1 https://orcid.org/000000016257901X
700    1_
$a Kirsch, Philipp $u Department of Radiology and Interventional Radiology, Donau Isar Klinikum Deggendorf, Perlasberger Str. 41, 94469 Deggendorf, Germany
700    1_
$a Rath, Stefan $u Department of Neurosurgery and Interventional Neuroradiology, Donau Isar Klinikum Deggendorf, Perlasberger Str. 41, 94469 Deggendorf, Germany
700    1_
$a Charvát, František $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague, Military University Hospital, U Vojenské Nemocnice 1200, 16902 Praha, Czech Republic
773    0_
$w MED00207994 $t Neurology international $x 2035-8385 $g Roč. 15, č. 4 (2023), s. 1480-1488
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38132975 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240105 $b ABA008
991    __
$a 20240116163019 $b ABA008
999    __
$a ok $b bmc $g 2036258 $s 1208810
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 15 $c 4 $d 1480-1488 $e 20231206 $i 2035-8385 $m Neurology international $n Neurol Int $x MED00207994
LZP    __
$a Pubmed-20240105

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace